These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 38705535)

  • 1. A chemically adjustable BMP6-IL6 axis in mesenchymal stem cells drives acute myeloid leukemia cell differentiation.
    Sun L; Rao S; Kerim K; Lu J; Li H; Zhao S; Shen P; Sun W
    Biochem Pharmacol; 2024 Jul; 225():116262. PubMed ID: 38705535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ATG5 regulates mesenchymal stem cells differentiation and mediates chemosensitivity in acute myeloid leukemia.
    Li Y; Jiang Y; Cheng J; Ma J; Li Q; Pang T
    Biochem Biophys Res Commun; 2020 Apr; 525(2):398-405. PubMed ID: 32098672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pretreatment of umbilical cord derived MSCs with IFN-γ and TNF-α enhances the tumor-suppressive effect on acute myeloid leukemia.
    Sun L; Wang J; Wang Q; He Z; Sun T; Yao Y; Wang W; Shen P
    Biochem Pharmacol; 2022 May; 199():115007. PubMed ID: 35307345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
    Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
    Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitamin D Receptor Controls Cell Stemness in Acute Myeloid Leukemia and in Normal Bone Marrow.
    Paubelle E; Zylbersztejn F; Maciel TT; Carvalho C; Mupo A; Cheok M; Lieben L; Sujobert P; Decroocq J; Yokoyama A; Asnafi V; Macintyre E; Tamburini J; Bardet V; Castaigne S; Preudhomme C; Dombret H; Carmeliet G; Bouscary D; Ginzburg YZ; de Thé H; Benhamou M; Monteiro RC; Vassiliou GS; Hermine O; Moura IC
    Cell Rep; 2020 Jan; 30(3):739-754.e4. PubMed ID: 31968250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. METTL3 mediates bone marrow mesenchymal stem cell adipogenesis to promote chemoresistance in acute myeloid leukaemia.
    Pan ZP; Wang B; Hou DY; You RL; Wang XT; Xie WH; Huang HF
    FEBS Open Bio; 2021 Jun; 11(6):1659-1672. PubMed ID: 33932138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.
    Azadniv M; Myers JR; McMurray HR; Guo N; Rock P; Coppage ML; Ashton J; Becker MW; Calvi LM; Liesveld JL
    Leukemia; 2020 Feb; 34(2):391-403. PubMed ID: 31492897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute Myeloid Leukemia Cells Educate Mesenchymal Stromal Cells toward an Adipogenic Differentiation Propensity with Leukemia Promotion Capabilities.
    Zhang L; Zhao Q; Cang H; Wang Z; Hu X; Pan R; Yang Y; Chen Y
    Adv Sci (Weinh); 2022 Jun; 9(16):2105811. PubMed ID: 35686138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
    Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
    Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.
    Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Larochelle A; Melenhorst JJ
    Stem Cell Res; 2015 Jan; 14(1):95-104. PubMed ID: 25535865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
    Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
    Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dimethyl fumarate and vitamin D derivatives cooperatively enhance VDR and Nrf2 signaling in differentiating AML cells in vitro and inhibit leukemia progression in a xenograft mouse model.
    Nachliely M; Trachtenberg A; Khalfin B; Nalbandyan K; Cohen-Lahav M; Yasuda K; Sakaki T; Kutner A; Danilenko M
    J Steroid Biochem Mol Biol; 2019 Apr; 188():8-16. PubMed ID: 30508646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional inhibition of mesenchymal stromal cells in acute myeloid leukemia.
    Geyh S; Rodríguez-Paredes M; Jäger P; Khandanpour C; Cadeddu RP; Gutekunst J; Wilk CM; Fenk R; Zilkens C; Hermsen D; Germing U; Kobbe G; Lyko F; Haas R; Schroeder T
    Leukemia; 2016 Mar; 30(3):683-91. PubMed ID: 26601782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
    Li L; Man J; Zhao L
    Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells enhance the impact of KIR receptor-ligand mismatching on acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia but not in those with acute lymphocytic leukemia.
    Zhang Y; Zheng H; Ren J; Luo X; Zheng Z; Zheng J; Zheng X; Chen Y; Chen Z; Hu J; Yang T
    Hematol Oncol; 2021 Aug; 39(3):380-389. PubMed ID: 33848027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bone Marrow Mesenchymal Stem Cells from Newly Diagnosed Acute Myeloid Leukemia Patients Exhibit Enhanced Osteogenic Differentiation Capacity].
    Ning HM; Wang J; Su YF; Xu C; Hu JW; Lou X; Li XS; Mao N; Chen H
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1277-1286. PubMed ID: 31418393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.